These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 23181718)

  • 1. The multiple origins of Type 1 diabetes.
    Pugliese A
    Diabet Med; 2013 Feb; 30(2):135-46. PubMed ID: 23181718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes.
    Brezar V; Carel JC; Boitard C; Mallone R
    Endocr Rev; 2011 Oct; 32(5):623-69. PubMed ID: 21700723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the etiology and mechanisms of type 1 diabetes.
    Pugliese A
    Discov Med; 2014 Sep; 18(98):141-50. PubMed ID: 25227755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental factors in the pathogenesis of type 1 diabetes mellitus.
    Knip M; Akerblom HK
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 3():S93-100. PubMed ID: 10522815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early childhood infections precede development of beta-cell autoimmunity and type 1 diabetes in children with HLA-conferred disease risk.
    Mustonen N; Siljander H; Peet A; Tillmann V; Härkönen T; Ilonen J; Hyöty H; Knip M;
    Pediatr Diabetes; 2018 Mar; 19(2):293-299. PubMed ID: 28597957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for preventing type I diabetes mellitus.
    Verge CF; Eisenbarth GS
    West J Med; 1996 Mar; 164(3):249-55. PubMed ID: 8775937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
    Campbell RK
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First-phase insulin response in young healthy children at genetic and immunological risk for Type I diabetes.
    Keskinen P; Korhonen S; Kupila A; Veijola R; Erkkilä S; Savolainen H; Arvilommi P; Simell T; Ilonen J; Knip M; Simell O
    Diabetologia; 2002 Dec; 45(12):1639-48. PubMed ID: 12488953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type 1 diabetes: role of intestinal microbiome in humans and mice.
    Boerner BP; Sarvetnick NE
    Ann N Y Acad Sci; 2011 Dec; 1243():103-18. PubMed ID: 22211896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 diabetes: etiology, immunology, and therapeutic strategies.
    van Belle TL; Coppieters KT; von Herrath MG
    Physiol Rev; 2011 Jan; 91(1):79-118. PubMed ID: 21248163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of genetic and non-genetic factors in type 1 diabetes.
    Hawa MI; Beyan H; Buckley LR; Leslie RD
    Am J Med Genet; 2002 May; 115(1):8-17. PubMed ID: 12116172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology and genetics of type 1 diabetes.
    Morran MP; Omenn GS; Pietropaolo M
    Mt Sinai J Med; 2008 Aug; 75(4):314-27. PubMed ID: 18729178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Environmental factors in the development of type 1 diabetes -- a new insight].
    Płaczkiewicz-Jankowska E; Szybiński Z; Huszno B
    Przegl Lek; 2007; 64(3):175-9. PubMed ID: 17941471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of low avidity T cells in the protection against type 1 diabetes: a modeling investigation.
    Khadra A; Santamaria P; Edelstein-Keshet L
    J Theor Biol; 2009 Jan; 256(1):126-41. PubMed ID: 18950644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the age-at-onset heterogeneity in type 1 diabetes through mathematical modeling.
    Wang X; He Z; Ghosh S
    Math Biosci; 2006 Sep; 203(1):79-99. PubMed ID: 16723139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why diabetes incidence increases--a unifying theory.
    Ludvigsson J
    Ann N Y Acad Sci; 2006 Oct; 1079():374-82. PubMed ID: 17130582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gut as a regulator of early inflammation in type 1 diabetes.
    Vaarala O
    Curr Opin Endocrinol Diabetes Obes; 2011 Aug; 18(4):241-7. PubMed ID: 21681088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.